Skip to main content
Caplight Logo









Demeter Bio Limited

Demeter Bio Limited

Private
LondonFrontier & Industrial Techhttps://www.demeter-bio.com/

Last Round

Early Funding

Jul 10, 2026

Est. Valuation

$4.42M

Total Funding Raised

$1.24M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Demeter Bio Limited is a biotechnology company that develops sustainable, bio-based materials and high-performance biopolymers as alternatives to toxic chemicals like PFAS for the textile, packaging, and cosmetic industries.

Sector

Frontier & Industrial Tech

Verticals

Sustainable Materials, Advanced Materials, Biotechnology, Circular Economy

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biopolymersPFAS alternativesbio-based coatingssustainable materialsper- and polyfluoroalkyl substancesPFASbiodegradable chemicalsgreen chemistrytextile coatingspackaging materialsbiotech materialsdrop-in replacementsclean techcircular economy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Demeter Bio Limited Comparables

Compare Demeter Bio Limited with similar companies based on industry and business-model similarity.

Demeter Bio Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ADN Coatings Ltd
82%
Melazyme
76%
BIOWEG
74%

Demeter Bio Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJul 10, 2026
GrantFeb 1, 2026
SeedMay 18, 2025
AcceleratorJan 1, 2025

Demeter Bio Limited Investors

Notable investors and investment history

Demeter Bio Limited investors
InvestorRounds
Innovate UKGrant
One Planet CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 31, 2026

    Open job postings increased from 0 to 1, representing 25% of headcount.

  • Jul 10, 2026

    $210K raised in early funding.

Demeter Bio Limited Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Demeter Bio Limited Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Demeter Bio Limited's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range4
Year Founded2025
Last FundingJul 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?